Depressive Symptoms
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Participants were randomly assigned to FBT-BN or CBT-A and completed measures of depressive symptoms and self-esteem before and after treatment and at 6- and 12-month follow-up assessments.
|
29446174 |
2018 |
Depressive Symptoms
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
The group-based CBT intervention, the Adolescent Coping with Depression Course (ACDC), has previously been evaluated within a quasi-experimental design, showing reduction in depressive symptoms compared to a benchmark of similar studies.
|
31117989 |
2019 |
Depressive Symptoms
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
RCT of an integrated CBT-HIV intervention on depressive symptoms and HIV risk.
|
29240757 |
2017 |
Depressive Symptoms
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
There was no significant post-treatment difference between CBT and other active psychological comparisons at reducing symptoms of depression.
|
28804915 |
2017 |
Depressive Symptoms
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Outcome will be assessed by measuring CCBT completion rate, comprehension of CBT concepts, and satisfaction with treatment, in addition to ratings of depressive symptoms, negative thoughts, and quality of life.
|
30572162 |
2019 |
Depressive Symptoms
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Insight in obsessive-compulsive disorder (OCD) refers to patients' recognition that their obsessions and compulsions are symptoms rather than necessary or natural thoughts and behaviors.<sup>1</sup> It has been estimated that 20% to 45% of youth with OCD exhibit poor or absent insight.<sup>2-4</sup> Identified correlates of poor insight include younger age,<sup>2,3,5,6</sup> increased OCD severity,<sup>2,4,7</sup> impairment,<sup>4,7,8</sup> and family accommodation<sup>2,4</sup>; lower intellectual and adaptive functioning<sup>3</sup>; and greater depressive symptoms.<sup>2,3</sup> Poorer insight has also been associated with reduced response across treatment groups (ie, selective serotonin reuptake inhibitor [SSRI], cognitive behavioral therapy [CBT], combined SSRI plus CBT, or pill placebo).<sup>9</sup>.
|
30071984 |
2018 |
Depressive Symptoms
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Culturally adapted CBT to address depressive symptoms among Latino immigrants appears promising but further research is needed.
|
27810273 |
2017 |
Depressive Symptoms
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Effective early treatment of youth anxiety, including CBT, medication, or CBT + medication, reduces risk for subsequent chronic depressive symptoms and suicidal behavior.
|
31356713 |
2019 |
Depressive Symptoms
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Contrary to findings of several previous studies, our results suggest no superiority of TF-CBT in comparison with WL regarding change in depressive symptoms in parents.
|
28051337 |
2017 |
Depressive Symptoms
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
The (cost) effectiveness of guided internet-based self-help CBT for dialysis patients with symptoms of depression: study protocol of a randomised controlled trial.
|
31775685 |
2019 |
Depressive Symptoms
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
To extend the sparse literature on moderators, we used time-varying effect modeling (TVEM; Tan, Shiyko, Li, Li, & Dierker, 2012) to examine how depressive symptoms and duration of generalized anxiety disorder (GAD) moderated effects of 3 treatments for GAD (applied relaxation [AR], cognitive-behavioral therapy [CBT], and nondirective therapy [ND]) over time using intensive repeated measures.
|
30714750 |
2019 |